ArticleTranslational lung cancer research2025

Comparative survival outcomes between EGFR-wildtype and EGFR-mutant lung adenocarcinoma following neoadjuvant chemoimmunotherapy: a retrospective cohort study from national cancer center in China.

Sikai Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.